CDT
CDT Equity Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.63
−16.56%0
Insider buys (3m)
4
Insider sells (3m)
-$2.9M
Net value (3m)
-90.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Regan Andrew · director, officer: Chief Executive Officer | Sale | 290 | $0.00 |
| Jun 23, 2026 | Taylor Mark Andrew · 10 percent owner | Sale | 5,000 | $0.71 |
| Jun 23, 2026 | Taylor Mark Andrew · 10 percent owner | Sale | 1,464,711 | $1.44 |
| Jun 23, 2026 | Taylor Mark Andrew · 10 percent owner | Sale | 593,289 | $1.40 |
| May 14, 2026 | Regan Andrew · director, officer: Chief Executive Officer | A-Award | 100,000 | $1.90 |
| May 14, 2026 | Regan Andrew · director, officer: Chief Executive Officer | A-Award | 147,401 | $0.00 |
| Feb 23, 2026 | Farley Chele Chiavacci · director | A-Award | 10,553 | $1.04 |
| Feb 23, 2026 | Farley Chele Chiavacci · director | A-Award | 1,940,804 | $0.00 |
| Dec 22, 2025 | Regan Andrew · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 224,800 | $1.79 |
| Dec 22, 2025 | Regan Andrew · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 3,685,815 | $0.00 |
| Sep 22, 2025 | Regan Andrew · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 1,120,000 | $0.69 |
| Sep 19, 2025 | Bligh James · director, officer: CFO | A-Award | 480,000 | $0.00 |
| Aug 26, 2025 | Lewis-Hall Freda C · director | A-Award | 15,000 | $1.89 |
| Aug 26, 2025 | Fry Simon Jeremy · director | A-Award | 35,000 | $0.00 |
| Aug 26, 2025 | Fry Simon Jeremy · director | A-Award | 15,000 | $1.89 |
| Aug 26, 2025 | Lewis-Hall Freda C · director | A-Award | 35,000 | $0.00 |
| Aug 26, 2025 | Farley Chele Chiavacci · director | A-Award | 35,000 | $0.00 |
| Aug 26, 2025 | Farley Chele Chiavacci · director | A-Award | 15,000 | $1.89 |
| Jun 13, 2025 | Regan Andrew · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 154,799 | $3.23 |
| Apr 17, 2025 | Charles Faith L. · director | A-Award | 115,194 | $0.87 |
| Apr 1, 2025 | Farley Chele Chiavacci · director | A-Award | 32,022 | $0.89 |
| Apr 1, 2025 | Charles Faith L. · director | A-Award | 46,629 | $0.89 |
| Apr 1, 2025 | Lewis-Hall Freda C · director | A-Award | 47,612 | $0.89 |
| Apr 1, 2025 | Fry Simon Jeremy · director | A-Award | 29,354 | $0.89 |
| Dec 20, 2024 | Lewis-Hall Freda C · director | A-Award | 420,000 | $0.07 |
| Dec 20, 2024 | Fry Simon Jeremy · director | A-Award | 420,000 | $0.07 |
| Dec 20, 2024 | Charles Faith L. · director | A-Award | 420,000 | $0.07 |
| Dec 20, 2024 | Farley Chele Chiavacci · director | A-Award | 420,000 | $0.07 |
| Nov 20, 2024 | Tapolczay David · director, officer: Chief Executive Officer | A-Award | 840,000 | $0.09 |
| Nov 20, 2024 | Farley Chele Chiavacci · director | A-Award | 299,238 | $0.09 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 2Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 110 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 2 | May 15, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026